Navigation Links
New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer
Date:5/16/2008

ROCHESTER, Minn., May 16 /PRNewswire-USNewswire/ -- This release is being sent in a social media format, by Mayo Clinic in conjunction with the National Cancer Institute, part of the NIH.

News:

* A new study being presented at the American Society of Clinical Oncology meeting in Chicago (Abstract #4020), may change treatment practice in about 25 percent of patients with colon cancer and is the basis for proposed changes to the way colorectal cancers will be staged.

* This new study, using National Cancer Institute (NCI) SEER population-based statistic registries from 1992 to 2004, and phase III clinical trial data, shows that outcomes of patients with positive nodes (Stage III) in colorectal cancer interact, to a greater extent than previously thought, with how deeply the cancer penetrates the bowel wall.

* Survival outcomes depend on the thickness of the primary cancer within or beyond the bowel wall in addition to whether nodes are positive or negative. A patient with a node positive 'thin' lesion (i.e., confined to the bowel wall) has a stage III cancer with better survival outcomes than a patient with a Stage II node negative 'thick' cancer that penetrates beyond the bowel wall. The current standard of practice for colon cancer patients is that all or most Stage III patients receive chemotherapy after surgical removal of their cancer, but Stage II patients do not routinely receive chemotherapy. In a separate National Cancer Data Base (NCDB) analysis, patients with Stage III colon cancers confined to the bowel wall who did not receive chemotherapy still had better survival than Stage II patients.

* Guidelines for adjuvant therapy may need re-examination in future clinical trials as well as more research into the molecular basis for the interplay between a primary cancer's ability to penetrate the bowel wall and to spread to regional nodes.

* Also, the survival of patients whose cancers invade beyond the bowel wall
'/>"/>

SOURCE Mayo Clinic Public Affairs; National Cancer Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New method proposed for determining which patients should get treatment for colorectal cancer
2. Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million
3. Air Methods Corporation Confirms Fatal Accident in Wisconsin
4. Air Methods Reports 1Q2008 Results and 2Q2008 Update
5. Integrium Introduces Its Integrium Clinical Excellence (ICE) Methodology to Assure Consistent Delivery of Sponsor Clinical Trials
6. New OPAL Therapy presents simple, cost-effective method of treating HIV infection
7. Air Methods to Report First Quarter Financial Results on Thursday, May 8, 2008
8. Determined a new method to establish the antioxidant capacity of extra virgin olive oil
9. Crime Scene Investigation methods could help in the battle against hospital infections
10. Air Methods Provides 1st Quarter Update
11. Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... A new mind-body medicine study c...) found that daily meditation, diaphragmatic breat...ife-enhancing physical, mental and emotional healt...k, NY (PRWEB) December 1, 2009 –– A ne... that meditation and yoga practices learned by stu...
(Date:12/1/2009)... The Daniel Jordan Fiddle Foundat...on to develop, advocate for, and support programs ...m Spectrum Disorders (ASD), has released a free in...sy & Seizures: How To Recognize The Signs and... New York, NY (PRWEB) December 1, 2009...
(Date:12/1/2009)... , NEWPORT BEACH, Calif., Dec. 1 /PRNewswire/ -... that insurers will reimburse them for the $20 cos...for ,going under, for surgery. ,, Anesthesiolog...onitoring is to avoid postop dementia from routine...ts have not heard the ,avoid over-medication, mess...
(Date:12/1/2009)... , BANGKOK, Dec. 1 What many sp...ry insiders and journalists has proclaimed in the ... capital. ,, Taking five citations including "...f the big winners in the fifth AsiaSpa Awards, pre...gnized spa and wellness publication, during a glit...
(Date:12/1/2009)... , SHENZHEN, China, Dec. 1 /PRNews...ore Ltd. (NYSE: NPD ) ("Nepstar" or "the Company...sed on the number of directly operated stores,tod...he third quarter ended,September 30, 2009. ,,...09, Nepstar terminated a voting rights assignment ...
Breaking Medicine News(10 mins):Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 2Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:Thailand - Spa Capital of Asia by Karen Emmons 2Health News:Thailand - Spa Capital of Asia by Karen Emmons 3Health News:Thailand - Spa Capital of Asia by Karen Emmons 4Health News:Thailand - Spa Capital of Asia by Karen Emmons 5Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 2Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 3Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 4Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 5Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 6Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 7Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 8Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 9Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 10Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 11Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 12Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 13
...rkers are three times as likely as all other child...ren to be uninsured, according to a report in the ...ent Medicine, one of the JAMA/Archives journals. ,...ady has suboptimal access to pediatric health serv...
...lth differences between groups of immigrants in Os...also great. The differences are seen for risk fact...port from the Norwegian Institute of Public Health...et health care better. , The five immigrant grou...
...21, Ask for an Injunction in Federal Court to Recl...2 Registered nurses for Riverside County, includi...iled a Fair Labor Standards Act (FLSA) class-actio...esent all 867 registered nurse members of SEIU 721...
...ile Reminder, the nation,s leading,comprehensive p...in industry,technology today at Javits Center in N...ng and distributing video testimonials can be used...th an effective,business strategy for increasing n...
...2 Are you unhappy with your smile but aren,t sure..., , The Pennsylvania Dental Association (PDA)...t to improve your smile. Your dentist can assess y.... , , , , Tooth whitening or bleac...
...esday, December 2, 2008 at 3 pm CST)--Radiology an...ersity of South Carolina in Charleston, S.C., toda...rom exposure to radiation during computed tomograp...archers presented their findings at the annual me...
Other Medicine News:Health News:1/3 of farm workers' children lack health insurance 2Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2
(Date:12/1/2009)... An expert from PAREXEL I...ng global biopharmaceutical services provider, wil... to drug development in Asia at the Partnerships i...eld December 1-3, 2009 at the Intercontinental Hot...rence, which is focused on maximizing efficiency a...
(Date:11/30/2009)...ewswire-FirstCall/ -- DATATRAK International, Inc....focused on global eClinical solutions for the clin...rma Focus AG (PFC) has joined its CRO Connect Prog... DATATRAK,s CRO partner training and offer its cli... addition, PFC will also have access to Partner pr...
(Date:11/30/2009)...30 Covance Inc. (NYSE: ... Piper Jaffray 21st Annual Health Care Conference ... Investors may access a live webcast of the presen... and download any necessary software, please log o...rs in Princeton, New Jersey, is one of the world,s...
Breaking Medicine Technology:PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 1Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 3Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 5Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 1Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 2Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 3Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 1Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 2Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 3
...nd Achieves All Key Endpoints for Both Efficacy an...ire-FirstCall/ --,Indevus Pharmaceuticals, Inc. to...rmacokinetic trial for NEBIDO (testosterone,undeca...rapy under,development for the treatment of male h...Schering Pharma AG, Germany. The data,from the rec...
...en(TM) is evaluating zonisamide SR as a novel comp...DIEGO, June 07, 2007 /PRNewswire-FirstCall/ -- Ore... company focused on the,treatment of central nervo...ty, today announced results from a Phase I trial e..., proprietary,sustained-release (SR) formulation ...
Other Medicine Technology:Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: